Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of JY09 Injection vs Dulaglutide in Adults with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
CTR20240359Phase 3Active
- Sponsor
- Beijing Eastern Biotech
- Start
- Jul 2024
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of JY-09 in type 2 diabetes mellitus (T2DM), sponsored by Beijing Eastern Biotech. Started Jul 2024; status: active.
02
Drugs
JY-09
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20240359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240359.